US$ 20.12
is bpc 157 safe for cancer patients Everyone's talking about peptides like this… so let's actually look at the science. Yes — there a study on BPC-157 and cancer. But it's a 2004 conference abstract (not even a BPC-157 Peptide: Enhance Healing and
Description
In formal pharmacokinetic studies in rats following intravenous administration, BPC-157 has a mean elimination half-life of approximately 15.2 minutes, with the peptide becoming undetectable within 4 hours

Patients should be prepared to discuss medical history, current medications, previous treatments, wellness goals, and recent lab work if available

Maybe being dogmatic and black and white in our thinking about this is not the best approach
Canadian buyers face additional considerations around import regulations and domestic shipping
